# SOLIQUA 100/33
> **BLA208673** · Biologics License Application · Sponsor: SANOFI-AVENTIS US · Approved 2016-11-21
## Drug
- **FDA Application Number:** BLA208673
- **Application type:** Biologics License Application
- **Brand name:** SOLIQUA 100/33
- **Generic name:** INSULIN GLARGINE AND LIXISENATIDE
- **Active ingredients:** INSULIN GLARGINE; LIXISENATIDE
- **Dosage form:** SOLUTION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** SANOFI-AVENTIS US
- **Manufacturer:** Sanofi-Aventis U.S. LLC
- **First approval:** 2016-11-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208673)
---
*AI Analytics · CC0 1.0*